- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT01857882
Decision Support Workshop for Breast Reconstruction (DSW)
Breast Reconstruction Decision Workshop Pilot RCT (Randomized Controlled Trial)
Přehled studie
Detailní popis
Typ studie
Zápis (Aktuální)
Fáze
- Nelze použít
Kontakty a umístění
Studijní místa
-
-
Ontario
-
Toronto, Ontario, Kanada, M5G 2C4
- Toronto General Hospital
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
Inclusion Criteria:
- Patient age: 18 - 79 years at the time of consultation
- In situ or invasive biopsy confirmed breast adenocarcinoma
- Considered for immediate or delayed breast reconstruction
- First consultation for breast reconstruction
Exclusion Criteria:
- Chest wall or atypical breast malignancy (ex: angiosarcoma) or inflammatory adenocarcinoma of the breast
- Completion any phase of reconstruction, or for revision reconstruction
- Patient cannot read or write in English.
- Cognitive impairment or uncontrolled psychiatric diagnosis
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Podpůrná péče
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Žádné (otevřený štítek)
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Experimentální: Decision Support Workshop
The decision support workshop will be 2 hours in duration on the morning of the consultation and will be facilitated by a dedicated social worker from psycho-oncology.
|
Incorporates the key components of shared decision-making and decision support with the philosophy of delivering supportive care to cancer patients.
|
|
Žádný zásah: Standard Care
Routine pre-consultation education
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Decision Self-efficacy Scale
Časové okno: Change from baseline decision self-efficacy at 1 week after surgical consultation
|
Decision self-efficacy (DSE) scale is a prospectively designed instrument to evaluate patient self-confidence in decision-making, including shared decision-making. It has been validated among women facing treatment decisions for osteoporosis and used in cancer patients. Psychometric evaluation has shown high levels of internal consistency (Cronbach alpha 0.90). Decision self-efficacy is correlated with decision conflict subscales of feeling informed (r = 0.47) and supported (r = 0.45). This instrument has never been tested in the breast cancer or breast reconstruction population. The total score is calculated by summing the 11 items, dividing by 11 and multiplying by 25. Scores range from 0 (extremely low self-efficacy) to 100 (extremely high self-efficacy). The mean and standard deviation (SD) were calculated at baseline and after the initial consultation. Change in score was defined as the difference in total score between baseline and after consultation. |
Change from baseline decision self-efficacy at 1 week after surgical consultation
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Decision Conflict Scale
Časové okno: Change from baseline decision conflict at 1 week after surgical consultation
|
Decision conflict scale measures personal perceptions of uncertainty in choosing options and has been demonstrated to be valid and responsive to change.
The decisional conflict scale is a 16-item 5-response instrument that reports a score from 0 - 100 with higher scores indicating more conflict (items are summed, divided by 16 and multiplied by 25).
|
Change from baseline decision conflict at 1 week after surgical consultation
|
|
Decision Preference and Decision Choice
Časové okno: baseline
|
Decision Preference and Decision Choice has been used as a primary and secondary outcome in studies of decision support interventions in cancer patients.
It demonstrates good test-retest reliability (test-retest coefficient > 0.90) and is sensitive to change when measured before and after an intervention.
|
baseline
|
|
Patient Involvement in Care Scale (PICS)
Časové okno: T1 (1 week after surgical consultation)
|
PICS is a measure of patient perception of involvement with her care, and has seven 5-point Likert scale items that assess the extent to which the patient asked questions, offered opinions, and expressed concerns when meeting with the surgeon.
|
T1 (1 week after surgical consultation)
|
|
Satisfaction With Information (Sub-scale of BREAST-Q)
Časové okno: T1 (1 week after surgical consultation)
|
The BREAST-Q is a procedure-specific and validated PRO that measures Hr-QOL and patient satisfaction with breast reconstruction.
The "Satisfaction with Information" Subscale specifically measures patient satisfaction with the preoperative information and care provided by the plastic surgeon and other members of the medical team.
There are 15 items that use a four-level Likert scale response format, the score is transformed on a scale of 0 to 100 with higher scores indicating greater satisfaction.
|
T1 (1 week after surgical consultation)
|
|
Qualitative Interview Assessment
Časové okno: Within three months after initial consultation
|
A subgroup of participants allocated to both the experimental and usual care groups will be asked to participate in a brief qualitative telephone interview.
Purposeful sampling will be used to recruit 5 patients from each group to achieve data saturation and variability.
Telephone interviews will be conducted by a social worker trained in qualitative methods.
All participants randomized to the workshop will additionally be asked to complete a written survey for evaluation of the intervention immediately after participation in the workshop.
|
Within three months after initial consultation
|
|
Uptake Rate of Breast Reconstruction-Service Outcome
Časové okno: Six months after initial consultation
|
The uptake rate of breast reconstruction (if patients chose breast reconstruction or no reconstruction)
|
Six months after initial consultation
|
|
Length of Consultation-service Outcome
Časové okno: Duration of initial consultation
|
The length of the initial consultation with the plastic surgeon, measured in minutes.
Consultations are expected to be between 20-60 mins.
|
Duration of initial consultation
|
|
Number of Consultations-service Outcomes
Časové okno: Six months after initial consultation
|
The number of consultations with the plastic surgeon until the patient has made a reconstruction choice (defined as signing a surgical consent form) will be recorded.
Patients can spend months considering their choices, so it is appropriate to follow them for a period of at least six months after their initial consultation.
|
Six months after initial consultation
|
|
Breast Reconstruction Knowledge Test
Časové okno: Change in baseline breast reconstruction knowledge at 1 week after initial consultation
|
This breast reconstruction knowledge test is a 12-item 3-response questionnaire that records the score on a continuous integer scale, and measured patient's knowledge regarding breast reconstruction.
|
Change in baseline breast reconstruction knowledge at 1 week after initial consultation
|
|
Medical Outcomes Study Social Support Survey
Časové okno: baseline
|
Medical Outcomes Study Social Support Survey has a series of 18 questions that measure 4 domains of social support (emotional, tangible, affectionate, and social interactions).
Responses range from 1 (none of the time) to 5 (all the time).
The items in each domain were summed and then transformed to yield scores ranging from 0 to 100.
Higher scores indicate more support.
|
baseline
|
Další výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Recruitment Rate-feasibility Outcome
Časové okno: Duration of recruiting, expected on average two months
|
As this is a pilot study, the feasibility of conducting the study is highly important.
The recruitment rate of participants will be measured, during the recruiting period which is expected to be on average two months.
|
Duration of recruiting, expected on average two months
|
|
Retention After Randomized Treatment Assignment (Workshop and Consultation Attendance)-Feasibility Outcome
Časové okno: Duration of treatment-8 hours on day of treatment
|
The number of participants who completed their assigned treatment (workshop and consultation vs. consultation alone) will be recorded.
This will be recorded directly after each day the treatment is delivered.
|
Duration of treatment-8 hours on day of treatment
|
|
Completion of Primary Outcome Measure-feasibility Outcome
Časové okno: 1 week after initial consultation
|
Patients are to complete the primary outcome one week after initial consultation.
However, it is expected that some patients may take longer to complete this intervention (on average 1 month after consultation), and will require reminder telephone calls.
|
1 week after initial consultation
|
Spolupracovníci a vyšetřovatelé
Spolupracovníci
Vyšetřovatelé
- Vrchní vyšetřovatel: Toni Zhong, MD, MHS, University Health Network, Toronto
Publikace a užitečné odkazy
Obecné publikace
- Causarano N, Platt J, Baxter NN, Bagher S, Jones JM, Metcalfe KA, Hofer SO, O'Neill AC, Cheng T, Starenkyj E, Zhong T. Pre-consultation educational group intervention to improve shared decision-making for postmastectomy breast reconstruction: a pilot randomized controlled trial. Support Care Cancer. 2015 May;23(5):1365-75. doi: 10.1007/s00520-014-2479-6. Epub 2014 Oct 29.
- Platt J, Baxter N, Jones J, Metcalfe K, Causarano N, Hofer SO, O'Neill A, Cheng T, Starenkyj E, Zhong T. Pre-consultation educational group intervention to improve shared decision-making in postmastectomy breast reconstruction: study protocol for a pilot randomized controlled trial. Trials. 2013 Jul 6;14:199. doi: 10.1186/1745-6215-14-199.
Užitečné odkazy
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia
Primární dokončení (Aktuální)
Dokončení studie (Aktuální)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Odhad)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Odhad)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Další relevantní podmínky MeSH
Další identifikační čísla studie
- 11-1027-CE
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .
Klinické studie na Rakovina prsu
-
Tianjin Medical University Cancer Institute and...Guangxi Medical University; Sun Yat-sen University; Chinese PLA General Hospital a další spolupracovníciDokončenoPrůvodce klinickou aplikací Conebeam Breast CTČína
-
Xijing HospitalAktivní, ne náborRakovina prsu | Rakovina prsu (Triple Negative Breast Cancer (TNBC))Čína
-
Shanghai Henlius BiotechZatím nenabírámeRakovina prsu (Triple Negative Breast Cancer (TNBC))Čína
-
Gangnam Severance HospitalNáborHER2 Enriched Subtype Cancer Breast, Herzuma, PAM50 StudyKorejská republika
-
BioNTech SESeventh Framework ProgrammeDokončenoRakovina prsu (Triple Negative Breast Cancer (TNBC))Švédsko, Německo
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH); Rising...NáborAnatomický karcinom prsu stadia II AJCC v8 | Anatomický karcinom prsu stadia III AJCC v8 | Rané stadium karcinomu prsu | Anatomic Stage I Breast Cancer American Joint Committee on Cancer (AJCC) v8Spojené státy
-
Emory UniversityNational Cancer Institute (NCI)StaženoPrognostický karcinom prsu stadia IV AJCC v8 | Metastatický maligní novotvar v mozku | Metastatický karcinom prsu | Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8
-
NRG OncologyNational Cancer Institute (NCI)DokončenoAnatomický karcinom prsu stadia IV AJCC v8 | Prognostický karcinom prsu stadia IV AJCC v8 | Metastatický maligní novotvar v kosti | Metastatický maligní novotvar v lymfatických uzlinách | Metastatický maligní novotvar v játrech | Metastatický karcinom prsu | Metastatický maligní novotvar v plicích | Metastatický... a další podmínkySpojené státy, Kanada, Saudská arábie, Jižní Korea
-
Jessica Mezzanotte SharpeNáborNemalobuněčný karcinom plic | Klasický Hodgkinův lymfom | Spinocelulární karcinom v ústech | Melanom (rakovina kůže) | Rakovina prsu (Triple Negative Breast Cancer (TNBC)) | Invazivní karcinom prsu | Renální buněčný karcinom (rakovina ledvin) | Rakovina konečníku s MSI-H/dMMRSpojené státy
Klinické studie na Decision Support Workshop
-
Istituto Ortopedico GaleazziUniversity of MilanDokončeno
-
University of PittsburghPatient-Centered Outcomes Research Institute; Northwell Health; University of...DokončenoZneužívání dětí | Trauma | Týrání dětí | Fyzické násilíSpojené státy
-
Temple UniversityNational Institute of Mental Health (NIMH)Dokončeno
-
Hospital Italiano de Buenos AiresDuke UniversityNeznámýRakovina prsuArgentina
-
US Department of Veterans AffairsDokončeno
-
DascenaNational Institute on Alcohol Abuse and Alcoholism (NIAAA); Baystate Health; Cape... a další spolupracovníciNáborSepse | Septický šok | Těžká sepseSpojené státy
-
Wuerzburg University HospitalCharite University, Berlin, Germany; Goethe University; RWTH Aachen University; Technical University of Munich a další spolupracovníciDokončenoChirurgická operace | Pacienti třídy ASA III/IV | Systémy podpory klinického rozhodováníNěmecko
-
University of ChicagoNational Cancer Institute (NCI)NáborRakovina prostaty | Adenokarcinom prostaty | Novotvar prostatySpojené státy
-
University of Wisconsin, MadisonAgency for Healthcare Research and Quality (AHRQ)NáborRiziko páduSpojené státy
-
University of Colorado, DenverNational Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)Aktivní, ne náborHarm Reduction | Předávkování opioidy | Předepisování opioidů | Zneužívání lékůSpojené státy